Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
Federal PolicyOctober 1, 2026

HRSA Names Manufacturers Approved for Expanded 340B Rebate Pilot

HRSA has disclosed which drug manufacturers are approved to participate in a revised 340B rebate pilot, under which ten drugmakers will shift 21 drugs from upfront discounts to after-the-fact rebate payments starting next year. The change expands on the administration's earlier rebate pilot attempt. Covered entities purchasing these drugs through 340B will need to pay full price at the point of sale and later seek rebates, rather than receiving discounts immediately. The shift takes effect at the start of next year.

Why it mattersCovered entities, including safety-net providers and clinics serving Medicaid patients, face cash-flow and administrative burdens from paying full price upfront and waiting for manufacturer rebates on 340B drugs.

Pharmacy

Read the full article at healthcaredive.com →
Share this briefing

You might also like

← All stories

Get the daily briefing.